Aspen Pharmacare Holdings Ltd (APN) - Total Liabilities
Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has total liabilities worth ZAC51.00 Billion ZAC (≈ $27.10 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Aspen Pharmacare Holdings Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Aspen Pharmacare Holdings Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. See Aspen Pharmacare Holdings Ltd (APN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Aspen Pharmacare Holdings Ltd Competitors by Total Liabilities
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PTT OIL+RET.BUS.-NVDR- 10
F:7F80
|
Germany | €84.11 Billion |
|
Power Integrations Inc
NASDAQ:POWI
|
USA | $98.88 Million |
|
Offshore Oil Engineering Co Ltd
SHG:600583
|
China | CN¥19.20 Billion |
|
Ambarella Inc
NASDAQ:AMBA
|
USA | $203.81 Million |
|
Scorpio Tankers Inc.
F:S0QA
|
Germany | €666.02 Million |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥3.02 Billion |
|
EQB Inc.
TO:EQB
|
Canada | CA$48.97 Billion |
|
Quálitas Controladora S.A.B. de C.V.
MX:Q
|
Mexico | MX$96.22 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Aspen Pharmacare Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Aspen Pharmacare Holdings Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aspen Pharmacare Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual total liabilities of Aspen Pharmacare Holdings Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | ZAC51.00 Billion ≈ $27.10 Million |
-6.07% |
| 2024-06-30 | ZAC54.29 Billion ≈ $28.85 Million |
+13.00% |
| 2023-06-30 | ZAC48.05 Billion ≈ $25.54 Million |
+18.83% |
| 2022-06-30 | ZAC40.43 Billion ≈ $21.49 Million |
-8.23% |
| 2021-06-30 | ZAC44.06 Billion ≈ $23.41 Million |
-31.11% |
| 2020-06-30 | ZAC63.95 Billion ≈ $33.99 Million |
-6.10% |
| 2019-06-30 | ZAC68.10 Billion ≈ $36.19 Million |
-17.69% |
| 2018-06-30 | ZAC82.74 Billion ≈ $43.97 Million |
+13.03% |
| 2017-06-30 | ZAC73.20 Billion ≈ $38.90 Million |
+18.45% |
| 2016-06-30 | ZAC61.80 Billion ≈ $32.84 Million |
+13.90% |
| 2015-06-30 | ZAC54.26 Billion ≈ $28.83 Million |
+1.09% |
| 2014-06-30 | ZAC53.67 Billion ≈ $28.52 Million |
+137.24% |
| 2013-06-30 | ZAC22.62 Billion ≈ $12.02 Million |
+57.98% |
| 2012-06-30 | ZAC14.32 Billion ≈ $7.61 Million |
+6.00% |
| 2011-06-30 | ZAC13.51 Billion ≈ $7.18 Million |
+51.55% |
| 2010-06-30 | ZAC8.91 Billion ≈ $4.74 Million |
+7.94% |
| 2009-06-30 | ZAC8.26 Billion ≈ $4.39 Million |
+9.68% |
| 2008-06-30 | ZAC7.53 Billion ≈ $4.00 Million |
+46.42% |
| 2007-06-30 | ZAC5.14 Billion ≈ $2.73 Million |
+102.17% |
| 2006-06-30 | ZAC2.54 Billion ≈ $1.35 Million |
+25.33% |
| 2005-06-30 | ZAC2.03 Billion ≈ $1.08 Million |
+94.55% |
| 2004-06-30 | ZAC1.04 Billion ≈ $554.39K |
+17.64% |
| 2003-06-30 | ZAC886.73 Million ≈ $471.25K |
-- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more